- What is LDS's primary focus?
- LDS is a biotechnology company that focuses on developing drug delivery systems based on liquid nano-sized delivery systems.
- What is the core technology behind LDS's drug delivery system?
- LDS's proprietary technology utilizes modified soft and fluid gel mesophases with characteristics between a liquid and a crystal. These mesophases contain water nano-channels packed in unique symmetries, which are thermodynamically stable and result in a long shelf life.
- What problems does LDS's technology aim to solve in drug delivery?
- LDS's technology enables the solubilization of large loads of poorly absorbed macromolecules, enhancing their transport across the gastrointestinal wall to the bloodstream without modifying the therapeutic compounds.
- What types of applications are included in LDS's project portfolio?
- LDS's portfolio comprises a range of projects including oral, ocular, and transdermal applications.
- What is the regulatory status of the components used in LDS's technology?
- The components used in LDS's technology are categorized as generally recognized as safe (GRAS) and/or are listed within the FDA Inactive Ingredient Guide database.
- When was LDS founded?
- LDS was founded in January 2012.
- Who are the founders of LDS?
- The founders of LDS are Nissim Garti, Prof., who serves as Founder & CEO, and Sharon Garti-Levi, PhD, who is the CTO & Co-founder.
- What is LDS's primary sector classification?
- LDS's primary sector is Health Tech & Life Sciences.
